Advertisement

Clinical and prognostic differences between surgically resected right-sided and left-sided colorectal cancer

  • Koji FukataEmail author
  • Norihiro Yuasa
  • Eiji Takeuchi
  • Hideo Miyake
  • Hidemasa Nagai
  • Yuichiro Yoshioka
  • Kanji Miyata
Original Article
  • 125 Downloads

Abstract

Purpose

A growing body of evidence suggests that right-sided colorectal cancer (RCRC) differs from left-sided colorectal cancer (LCRC) in certain clinicopathological features. Therefore, we investigated the difference between RCRC and LCRC in a series of 899 patients.

Methods

We reviewed data retrospectively, from 899 patients who underwent R0-resection for stage II and III CRC and compared the clinicopathological factors between patients with RCRC and LCRC.

Results

The patients with RCRC tended to be older, more likely female, with a larger tumor, higher pathological T stage, and a greater proportion of their tumors were poorly differentiated adenocarcinoma, mucinous adenocarcinoma, or signet ring cell carcinoma than the patients with LCRC,. Recurrence-free survival (RFS) of the patients with RCRC tended to be higher than that of the patients with LCRC and was significantly better among patients with stage II cancer. The overall survival (OS) was similar for patients with RCRC and LCRC, irrespective of cancer stage.

Conclusion

Compared with the patients with LCRC, those with RCRC had several oncologically unfavorable factors, with better RFS in stage II and similar OS in stages II and III. These results suggest that the biological aggressiveness of RCRC is lower than that of LCRC in stage II; however, it can increase after relapse.

Keywords

Colorectal cancer Right-sided colon Prognosis 

Notes

Compliance with ethical standards

Conflict of interest

We have no conflicts of interest to declare.

References

  1. 1.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefGoogle Scholar
  2. 2.
    Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Int Med. 1990;113(10):779–88.CrossRefGoogle Scholar
  3. 3.
    Iacopetta BI. Are there two sides to colorectal cancer? Int J Cancer. 2002;101(5):403–8.CrossRefGoogle Scholar
  4. 4.
    Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomark Prev. 2003;12(8):755–62.Google Scholar
  5. 5.
    Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, Laurberg S, Laiho P, Aaltonen LA, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut. 2005;54(3):374–84.CrossRefGoogle Scholar
  6. 6.
    Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right-versus left-sided colon cancers? Ann Surg Oncol. 2008;15(9):2388–94.CrossRefGoogle Scholar
  7. 7.
    Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53(1):57–64.CrossRefGoogle Scholar
  8. 8.
    Suttie SA, Shaikh I, Mullen R, Amin AI, Daniel T, Yalamarthi S. Outcome of right and left sided colonic and rectal cancer following surgical resection. Colorectal Dis. 2011;13(8):884–9.CrossRefGoogle Scholar
  9. 9.
    Weiss JM. Mortality by stage for right- versus left-sided colon. J Clin Oncol. 2011;29(33):4401–9.CrossRefGoogle Scholar
  10. 10.
    Konishi T, Yamaguchi T, Ueno M, Fukunaga Y, Nagayama S, Fujimoto Y, et al. Impact of right-sided tumor location on survival in stage II–III colorectal cancer: implication for adjuvant chemotherapy. Stomach Intestine. 2012;47(13):1989–99 (in Japanese with English abstract).Google Scholar
  11. 11.
    Moritani K, Hasegawa H, Okabayashi K, Ishii Y, Endo T, Kitagawa Y. Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at single institution. Surg Today. 2014;44(9):1685–91.CrossRefGoogle Scholar
  12. 12.
    Huang CW, Tsal HL, Huang MY, Huang CM, Yeh YS, Ma CJ, et al. Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer. World J Surg Oncol. 2015;13(1):257.CrossRefGoogle Scholar
  13. 13.
    Warschkow R, Sulz MC, Marti L, Tarantino I, Schmied BM, Cerny T. Better survival in right-sided versus left-sided stage I–III colon cancer patients. BMC Cancer. 2016;16(1):554.CrossRefGoogle Scholar
  14. 14.
    Qin Q, Yang L, Sun YK, Ying JM, Zhang W, Wang JW, et al. Comparison of 627 patients with right- and left-sided colon cancer in China: differences in clinicopathology, recurrence, and survival. Chronic Dis Transl Med. 2017;3(1):51–9.CrossRefGoogle Scholar
  15. 15.
    Lim DR, Kuk JK, Kim T, Shin EJ. Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection. Which side is better outcome? Medicine (Baltimore). 2017;96(42):e8241.CrossRefGoogle Scholar
  16. 16.
    Ishihara S, Murono K, Sasaki K, Yasuda K, Otani K, Nishikawa T, et al. Impact of primary tumor location on postoperative recurrence and subsequent prognosis in nonmetastatic colon cancers: a multicenter retrospective study using a propensity score analysis. Ann Surg. 2018;267(5):917–21.CrossRefGoogle Scholar
  17. 17.
    Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajopka Y. Japanese society for cancer of the colon and rectum guidelines 2010 for treatment of colorectal cancer. Int J Clin Oncol. 2012;17(1):1–29.CrossRefGoogle Scholar
  18. 18.
    Sobin L, Gospodarowicz ML, Wittekind Ch. TNM classification of malignant tumors. New York: Wiley; 2010.Google Scholar
  19. 19.
    Hansen IO, Jess P. Possible better long-term survival in left versus right-sided colon cancer—a systematic review. Dan Med J. 2012;59(6):A4444.PubMedGoogle Scholar
  20. 20.
    Wong R. Proximal tumors are associated with greater mortality in colon cancer. J Gen Intern Med. 2010;25(11):1157–63.CrossRefGoogle Scholar
  21. 21.
    Petrelli F, Tomasello G, Borgonovo K, Ghidini M, Turati L, Dallera P, et al. Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol. 2016;3(2):211–9.CrossRefGoogle Scholar
  22. 22.
    Price TJ, Beeke C, Ullah S, Padbury R, Maddern G, Roder D, et al. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer. 2015;121(6):830–5.CrossRefGoogle Scholar
  23. 23.
    Loupakis F, Yang D, Yau L, Feng S, Cremolini C, Zhang W, et al. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst. 2015;107(3):dju427.CrossRefGoogle Scholar
  24. 24.
    Pai RK, Jayachandran P, Koong AC, Chang DT, Kwok S, Ma L, et al. BRAF-mutated, microsatellite stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am J Surg Pathol. 2012;36(5):744–52.CrossRefGoogle Scholar
  25. 25.
    Merok MA, Ahlquist T, Royrvik EC, Tufteland KF, Hektoen M, Sjo OH, et al. Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol. 2013;24(5):1274–82.CrossRefGoogle Scholar
  26. 26.
    Tran B, Kopetz S, Tie J, Gibbs P, Jiang ZQ, Lieu CH, et al. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer. 2011;117(200):4623–32.CrossRefGoogle Scholar
  27. 27.
    Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073–87.CrossRefGoogle Scholar
  28. 28.
    Goldstein J, Tran B, Ensor J, Gibbs P, Wong HL, Wong SF, et al. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol. 2014;25(5):1032–8.CrossRefGoogle Scholar
  29. 29.
    Chen KH, Lin YL, Liau JY, Tsai JH, Tseng LH, Lin LN, et al. BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer. Med Oncol. 2016.  https://doi.org/10.1007/s12032-016-0756-6 (Epub 2016 Mar 31).CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Missiaglia E, Jacobs B, D’Ario G, Di Narzo AF, Soneson C, Budinska E, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014;25(10):1995–2001.CrossRefGoogle Scholar
  31. 31.
    Zhang J, Zheng J, Yang Y, Lu J, Gao J, Lu T, et al. Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases. Sci Rep. 2015;5:18678.CrossRefGoogle Scholar
  32. 32.
    Shimada Y, Kameyama H, Nagahashi M, Ichikawa H, Muneoka Y, Yagi R, et al. Comprehensive genomic sequencing detects important genetic differences between right-sided and left-sided colorectal cancer. Oncotarget. 2017;8(55):93567–79.CrossRefGoogle Scholar
  33. 33.
    Van Cutsem E, Köhne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360(14):1408–17.CrossRefGoogle Scholar
  34. 34.
    Douillard JY, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369(11):1023–34.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Koji Fukata
    • 1
    Email author
  • Norihiro Yuasa
    • 1
  • Eiji Takeuchi
    • 1
  • Hideo Miyake
    • 1
  • Hidemasa Nagai
    • 1
  • Yuichiro Yoshioka
    • 1
  • Kanji Miyata
    • 1
  1. 1.Department of Gastrointestinal SurgeryJapanese Red Cross Nagoya First HospitalNagoyaJapan

Personalised recommendations